Fig. 3From: Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approachConcentrations of generated thrombin when low recombinant tissue factor (LTF) or high recombinant tissue factor (HTF) amounts were added to samples of platelet rich plasma (PRP) from platelet apheresis product (as control) or to samples of SRGF pool batches comprising n = 16 single donor specimens. Thrombin availability in SRGF was demonstrated to be undetectableBack to article page